Recruiting now
-
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
Phase 2 · randomised · 1,109 people · 47 sites in 8 countries · Recruiting now
-
A Clinical Study of Arfolitixorin in Patients With mCRC
Phase 2 · randomised · 90 people · 3 sites in Germany · Recruiting now
-
SCRT + Chemo Targeted Immuno-neoadjuvant Therapy for High-risk pMMR/MSS RC
Phase 3 · randomised · 204 people · 1 site in China · Recruiting now
-
Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced Rectal Cancer
Phase 2 · randomised · 66 people · 1 site in United States · Recruiting now
-
Neoadjuvant Botensilimab and Balstilimab for the Treatment of Advanced Resectable Colorectal Cancer NEST3
Phase 2 · 100 people · 11 sites in United States · Recruiting now
-
Radiotherapy + Systemic Therapy as Conversion Therapy for pMMR/MSS T4M0 Colon Cancer（Neo-Color）
Phase 2 · randomised · 128 people · 1 site in China · Recruiting now